By Melissa Fassbender
AMRI and The RNA Institute at UAlbany have entered into a collaboration to advance the discovery and development of RNA-based therapeutics and research tools.
AMRI, which works in drug contract research, development and manufacturing, will use tools and quality assessment standards from the institute for its clients’
“RNA holds great promise for designing drugs that treat numerous diseases, such as breast cancer, Alzheimer’s disease, and HIV…”
“The RNA Institute at the University at Albany is settling into its niche as a technology development center…”
“Poor RNA. It has never managed to attract the scientific spotlight that DNA has…”
“As researchers across the country try to come up with treatment and drugs for things like Cancer, HIV and Ebola, scientists at the University at Albany…”
The RNA Institute of University at Albany has received a gift, valued at $400,000, that will greatly enhance its ribonucleic acid-based research capabilities.